Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer
摘要：
Poor prognoses for colorectal cancer (CRC) patients with metastatic lesions have driven demand for the development of novel targeted therapies. Here we demonstrate that expression of bone morphogenetic protein 4 (BMP-4) is universally upregulated in human CRC cells and tissues, resulting in activated BMP signaling. Inhibition of endogenous BMP signaling by the BMP type I receptor inhibitor LDN-193189 elevated expression of the phosphatase DUSP5 in CRC cells, inducing apoptosis via dephosphorylation of Erk MAPK. Administering LDN-193189 to mice diminished tumor formation of CRC cells. Our findings suggest inhibition of autocrine BMP-4 as a candidate treatment strategy for CRC. Copyright 2017, American Association for Cancer Research.
展开
DOI：
10.1158/0008-5472.CAN-17-0112
被引量：
年份：
2017
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
来源期刊
引用走势
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
